Isepamicin

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search

Template:Short description Template:Drugbox Isepamicin (isepamycin) is an aminoglycoside antibiotic.

It was patented in 1973 and approved for medical use in 1988.[1] It has been identified by the World Health Organization as a Critically Important Antimicrobial for human use.[2]

Synthesis

Isepamicin can be synthesized by derivatization of gentamicin B (1) with benzyl N-[(2S)-3-(2,5-dioxopyrrolidin-1-yl)-2-hydroxy-3-oxopropyl]carbamate (2), followed by deprotection.[3][4][5][6]

File:Isepamicin synthesis.svg
Synthesis of isepamicin from gentamicin B

References

<templatestyles src="Reflist/styles.css" />

  1. Script error: No such module "citation/CS1".
  2. Script error: No such module "citation/CS1".
  3. Serradell, MN; Blancafort, P.; Roberts, PJ; Castaer, J.; SCH-21420. Drugs Fut 1979, 4, 7, 525.
  4. John J. Wright, U.S. patent 4029882 (1977 to Merck Sharp and Dohme Corp).
  5. Thieme
  6. ChemDrug

Script error: No such module "Check for unknown parameters".

Script error: No such module "Navbox".


Template:Asbox